Title: A Comparative study of Tuberculosis MDR Cases in HIV and non –HIV Person of Coal field area of Dhanbad
Authors: Dr Sujeet Kumar Tiwary, Dr Binay Kumar Singh, Dr Sunil Kumar Sinha, Rupesh Kumar, Dr Ajay Kumar
DOI: https://dx.doi.org/10.18535/jmscr/v8i2.95
Abstract
The HIV and Tuberculosis is one of the major health challenges in the present time. Many people’s suffering co-infection with HIV and tuberculosis in Jharkhand and other state of India. Mycobacterium tuberculosis is the most common cause of Tuberculosis because of airborne transmission mode.{1,2}HIV may be transmitted through sexual intercourse and certain body fluids that are capable of containing high concentration of HIV. These fluids included blood semen, vaginal and rectal secretions. HIV weakens the immune system and increase the risk of TB {3,}.HIV with TB is called HIV /TB co-infection {3, 4}. This study will focus on HIV/TB co-infection having Multi drug resistant tuberculosis.{4,} this study is done with the name, address, and any other contacts of the Person will be kept secret.
Materials and Methods: All Study was done at the department of Microbiology PMCH Dhanbad from December 2018 to December2019 with the help of RNTCP Designated Microscopy centers (DMC) and Integrated Counseling and Testing center (ICTC) at PMCH Dhanbad. All 262 blood and sputum samples were collected in the (Designated Microscopy Centre) RNTCP and Integrated Counseling and Testing center at Patliputra Medical college and hospital. All blood / sputum samples were sent to the Central Research laboratory PMCH Dhanbad.
Result: In our study we have found that the Tuberculosis infection is much higher than for HIV. In this study we have found the HIV/TB co infected Patients Rifampicin drug resistant percentage is higher than for Isoniazid drug. This investigation non-infection HIV patients and co- infected HIV/TB patients Isoniazid less resistant than Rifampicin.
Keywords: Rifampicin, Isoniazid, Fluorescence Microscopy, MGIT, Multi drug Resistant.
References
- World Health Organization (2012). Global Tuberculosis report 2012.ISBN978-924-156450-2.
- World Health Organization (1999). Tuberculosis infection control in the era of expanding HIV care and treatment.
- Bruchfeld, G. Aderaye, I.B Palme et.all ‘’Molecular epidemiology and drug resistance of Mycobacterium Tuberculosis isolates from Ethiopian pulmonary tuberculosis patients with and without immunodeficiency Virus infection.’’ Journal of Clinical Microbiology. Vol.40,no5,pp.1636-1643,2002
- demissi, E lemma, M, Gebeyehu, and B Lindtjorn ‘’senstivity to anti- tuberculosis drugs in HIV positive and negative patients in Addis Ababa’’ Scandinavian journal of infection desease, vol, 33no-12.
- Van Soolingen ‘’Molecular epidmology of tuberculosis and other mycobacterial infection: main methodologis and achivents ‘’ journal of internal medicine, vol.249,no.pp 1-26,2001
- WHO,’’ Global tuberculosis report 2012’’ Tech.rep World Health Organization Geneva Switzerland, 2012.
- c Boehme, P Nabeta, D. Hillemann er all ‘’Rapid molecular detection of tuberculosis and rifampicin resistance’’ New England journal of Medicine.
- World Health organization (WHO).2013b. Definitions and reporting framework for tuberculosis-2013. World Health organization, Geneva.
- Centers for Disease Control and Prevention .2013. Provisional CDC guideline for the use and safety monitoring of bedaquline fumrate for the treatment of Multidrug resistant tuberculosis. MMWR Rep: 62.
- Ahuja SD, Ashink D, Avendan M, Banerjee Burgos M,Centies R, eral. 2012. Multidrug resistant pulmonary tuberculosis treatment regimens and patients out comes. An individual patient data Meta –analysis of9, 513 patients Med 9: e1001300.
- WHO, Global tuberculosis reports2015’ Tech Rep...Molecular detection of tuberculosis and other mycobacterium infection main methodologies and achivents Journal of Internal Medcine, vol.249.no1, pp1-26, 2001.
- Rifat, A.H.Milton, J Hall et al., in Bagladesh a casecontrol study on risk factors ‘’vol.2015 Article ID 215015, 10pages, 2015.
- World Health Organization ‘’ tuberculosis infection control in the era of expanding HIV Care and treatment ‘’ tuberculosis and HIV January 2013.
- Curry international Tuberculosis Centre, California Department of public Health 2012. Tuberculosis Drug information.